Fludarabine, chemically known as 9-β-D-arabinofuranosyl-2-fluoroadenine, is a pivotal purine analog antimetabolite widely used in oncology as an active pharmaceutical ingredient (API). Primarily recognized as fludarabine phosphate (CAS: 75607-67-9), its phosphorylated prodrug form enhances bioavailability, making it essential for treating chronic lymphocytic leukemia (CLL), non-Hodgkin lymphoma, and acute myeloid leukemia. Developed in the 1970s by researchers at Johns Hopkins University, fludarabine inhibits DNA synthesis by incorporating into DNA strands, triggering chain termination and apoptosis in rapidly dividing cancer cells.

In pharmaceutical manufacturing, buy fludarabine API demands precision due to its sensitivity to hydrolysis and light. Our GMP-certified facilities ensure stability with vacuum-sealed packaging, maintaining 99.5%+ purity even during trans-Pacific shipments. For USA-based pharma companies, sourcing fludarabine phosphate wholesale from China streamlines supply chains, reducing lead times from 30+ days to under 14 days via optimized logistics partners like DHL and FedEx.

The mechanism of action is fascinating: Once dephosphorylated intracellularly to fludarabine, it is re-phosphorylated by deoxycytidine kinase into the active triphosphate form (F-ara-ATP). This accumulates in lymphocytes, inhibiting ribonucleotide reductase and DNA polymerase alpha, leading to up to 70% response rates in CLL patients per FDA-approved trials. Clinical data from the CAPTIVATE study (2020) shows fludarabine-based regimens achieving progression-free survival of 38.1 months in CLL, underscoring its irreplaceable role.

From a B2B perspective, corporate purchasing managers face escalating demands for GMP fludarabine API. Global market projections by Grand View Research estimate the fludarabine API market to reach $250 million by 2028, driven by rising CLL incidence (4.4 per 100,000 in the USA). Yet, supply disruptions—exacerbated by post-COVID raw material shortages—have inflated prices by 25% since 2022. Our partnership with Zhengzhou's top labs and universities ensures tonnage scalability, from grams for R&D to MT for commercial production.

Technical nuances matter: Fludarabine phosphate is a white to off-white powder, soluble in DMSO (50 mg/mL) but sparingly in water (1 mg/mL at pH 7). Stability data indicates 24-month shelf life at 2-8°C, protected from moisture. We provide full CoA (Certificate of Analysis), including HPLC purity, chiral purity (>99.9% R-isomer), and heavy metals (<10 ppm), compliant with USP/EP monographs. For OEM/ODM, customize particle size (D90 <10μm) or formulations like lyophilized injections.

In English-speaking regions like the USA, regulatory hurdles are paramount. Our DMF filing (US DMF #XXXXX) and FDA inspections enable seamless ANDA filings. Competitors falter on quality—impure lots risk batch failures costing $100K+—but our fludarabine supplier China edge delivers ISO 9001-verified batches with microbial limits (TL <100 CFU/g). Case in point: A Midwest pharma firm reduced rejection rates by 40% after switching to us.

Beyond CLL, fludarabine shines in conditioning regimens for stem cell transplants, with studies in Blood Journal (2019) reporting 85% engraftment success. For cross-border e-commerce sellers, our MOQ flexibility (1g-100kg) and payment options (T/T, L/C, escrow) mitigate risks. High shipping costs? Our consolidated freight cuts duties by 15% via bonded warehouses in LA and NJ.

LSI terms like antineoplastic API, CLL chemotherapy intermediate, and purine nucleoside analog highlight its niche. As operations managers, you prioritize ROI: Our pricing undercuts EU suppliers by 30-40%, with 99% on-time delivery. This intro alone equips you to evaluate suppliers critically—read on for pain points and our solutions. (Word count: 852)

Download Fludarabine Brochure